The Next Generation of Targeting Therapeutics ANNAM Biosciences is a technology development company in the U.S., founded with the aim of providing a bridge to the commercialization of the most transformative drug delivery technologies and drug candidates. Operated by a Management Team with significant experience in Life Sciences, ANNAM is well positioned to maximize the potential of the inventions it licenses. What We Do ANNAM' strategy is to out-license drug delivery technologies and drug candidates to each of our spin-off companies and to provide all of the operational, research, development, and business partnering support the company requires during the initial stages of its development. In 2013, Annam licensed its technology to Annam Pharma, Inc. (oncology company) and deMicrobe (antibiotic company). For further details, please visit our spin-off companies page.